Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.365 HKD | +5.80% | +8.96% | -41.13% |
04-05 | CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11% | MT |
03-19 | CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 1,932
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health
60.9
%
| 3,097 | 58.7 % | 3,243 | 60.9 % | +4.71% |
Agriculture-related
39.1
%
| 2,178 | 41.3 % | 2,079 | 39.1 % | -4.55% |
Unallocated
0.0
%
| 1 | 0.0 % | 1 | 0.0 % | +42.49% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia Pacific
53.3
%
| 3,048 | 57.8 % | 2,837 | 53.3 % | -6.91% |
North America
46.7
%
| 2,227 | 42.2 % | 2,485 | 46.7 % | +11.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ying Choi Yu
CEO | Chief Executive Officer | 69 | 02-05-31 |
Yiu Leung Mo
DFI | Director of Finance/CFO | 64 | 05-09-30 |
Hing Lam Kam
PSD | President | 77 | 02-05-31 |
Pak To Wu
COO | Chief Operating Officer | 62 | 21-01-31 |
Mai Kuen Lee
ADM | Chief Administrative Officer | 64 | 02-02-28 |
Kean Meng Toh
CTO | Chief Tech/Sci/R&D Officer | 57 | 07-12-31 |
Tak Chuen Ip
CIO | Chief Investment Officer | 71 | 00-12-31 |
Wai Man Ho
PRN | Corporate Officer/Principal | 58 | 04-01-31 |
Wai Yin Yan
AUD | Comptroller/Controller/Auditor | 54 | 10-03-31 |
King Sang Hon
LAW | General Counsel | 69 | 02-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Lee Kwok
BRD | Director/Board Member | 82 | 02-05-31 |
Tzar Kuoi Li
CHM | Chairman | 59 | 02-03-31 |
Hing Lam Kam
PSD | President | 77 | 02-05-31 |
Tak Chuen Ip
CIO | Chief Investment Officer | 71 | 00-12-31 |
Ying Choi Yu
CEO | Chief Executive Officer | 69 | 02-05-31 |
Peter Tulloch
BRD | Director/Board Member | 79 | 02-03-31 |
Kai Cheong Kwan
BRD | Director/Board Member | 74 | 15-03-23 |
Kean Meng Toh
CTO | Chief Tech/Sci/R&D Officer | 57 | 07-12-31 |
Donald Roberts
BRD | Director/Board Member | 72 | 20-07-14 |
Director/Board Member | 68 | 19-06-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,611,073,000 | 2,404,637,115 ( 25.02 %) | 0 | 25.02 % |
Company contact information
CK Life Sciences International (Holdings), Inc.
2 Dai Fu Street Tai Po Industrial Estate
, Hong Kong
+852 2126 1212
http://www.ck-lifesciences.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-41.13% | 424M | |
+11.32% | 7.78B | |
+1.64% | 7.38B | |
+10.50% | 6.52B | |
-6.69% | 3.67B | |
-13.33% | 3.44B | |
-10.10% | 1.17B | |
+8.34% | 934M | |
-42.76% | 879M | |
-19.71% | 836M |
- Stock Market
- Equities
- 775 Stock
- Company CK Life Sciences Int'l., (Holdings) Inc.